Skip to main content

Table 2 Comparison of clinical baseline characteristics

From: High miR-200a-3p expression has high diagnostic values for hypertensive disorders complicating pregnancy and predicts adverse pregnancy outcomes

Parameters NC (N = 50) HDCP (N = 126)
GH (N = 50) MP (N = 42) SP (N = 34)
Age (year) 29.2 ± 3.5 28.5 ± 3.2 28.7 ± 3.7 29.1 ± 4.2
Gestational age (week) 32.8 ± 2.4 33.1 ± 1.7 32.5 ± 1.9 33.4 ± 2.3
Gravidity (time) 1.72 ± 0.54 1.70 ± 0.51 1.71 ± 0.55 1.79 ± 0.48
Parity (time) 1.13 ± 0.27 1.08 ± 0.27 1.12 ± 0.30 1.09 ± 0.29
BMI (kg/m2) 25.0 ± 2.0 24.9 ± 2.2 25.1 ± 2.2 25.0 ± 2.25
SBP (mmHg) 121.4 ± 9.2 144.9 ± 7.2a 159.4 ± 12.2ab 175.5 ± 17.7abc
DBP (mmHg) 75.1 ± 7.1 96.5 ± 8.8a 110.2 ± 10.4ab 120.9 ± 12.1abc
PLT (× 109/L) 222.1 ± 19.8 165.4 ± 16.2a 134.2 ± 13ab 89.5 ± 13abc
S-Cr (umol/L) 43.4 ± 7.1 67.1 ± 9.7a 98.9 ± 11.5ab 123.9 ± 9.9abc
AST (U/L) 29.3 ± 5.7 47.5 ± 9.1a 66.7 ± 8.0ab 80.0 ± 9.5abc
ALT (U/L) 17.8 ± 3.4 29.2 ± 6.0a 47.5 ± 5.8ab 59.6 ± 7.4abc
LDH (U/L) 143.2 ± 10.4 164.6 ± 11.9a 181.6 ± 14.6ab 208.9 ± 13.5abc
24-h urine protein (g) 0.05 ± 0.01 0.17 ± 0.03a 0.50 ± 0.13ab 2.88 ± 0.62abc
Gestational week of delivery (W) 39.8 ± 0.3 38.6 ± 0.5a 37.8 ± 0.6ab 37.2 ± 0.4abc
Fetal weight (g) 3963 ± 565 3385 ± 486a 3016 ± 463ab 2664 ± 472abc
S/D 2.36 ± 0.32 3.27 ± 0.35a 3.96 ± 0.41ab 4.52 ± 0.43abc
FGR 3 (6%) 9 (18%)a 15 (35.7%)ab 19 (55.9%)abc
  1. BMI Body Mass Index, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, PLT Platelet count, S-Cr Serum Creatinine, AST Aspartate Transaminase, ALT Alanine Transaminase, LDH Lactate Dehydrogenase, S/D Fetal umbilical artery Systolic to Diastolic ratio, FGR Fetal Growth Restriction
  2. The measurement data were expressed as mean ± standard deviation. One-way ANOVA or Chi-square test was used for comparisons between 2 groups.
  3. a Represented compared with the NC group, P < 0.05;
  4. b Represented compared with the GH group, P < 0.05;
  5. c Represented compared with the MP group, P < 0.05